Company Filing History:
1 out of 1,210 
1 out of 1,187 
1 out of 444 
Years Active: 2022
Title: The Innovations of Roger Schilling
Introduction
Roger Schilling is an accomplished inventor based in Vineyard Haven, MA (US). He has made significant contributions to the field of medicine, particularly in the treatment of metabolic conditions such as diabetes. His innovative work has led to the development of a patent that showcases his expertise and dedication to improving health outcomes.
Latest Patents
Roger Schilling holds a patent for the selective inhibition of gluconeogenic activity. This invention provides compounds, pharmaceutical compositions, and methods for treating and/or preventing metabolic conditions, including diabetes. His work in this area highlights the potential for new therapeutic approaches to manage such diseases effectively.
Career Highlights
Throughout his career, Roger has worked with prestigious institutions, including Dana-Farber Cancer Institute and The Scripps Research Institute. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Roger has collaborated with notable colleagues, including Pere Puigserver and Kfir Sharabi. These partnerships have enriched his research and expanded the impact of his inventions.
Conclusion
Roger Schilling's contributions to the field of medicine through his innovative patent and collaborations with esteemed institutions and colleagues demonstrate his commitment to advancing healthcare solutions. His work continues to inspire future innovations in the treatment of metabolic conditions.